News | Cath Lab | December 28, 2015

Boston Scientific Chariot Guiding Sheath May Break off During Procedures

December 28, 2015 — The U.S. Food and Drug Administration (FDA) said Boston Scientific has started a Class I recall of its Chariot Guiding Sheath after receiving 14 complaints of the shaft of the device separating. This can cause small pieces to break off the device and enter the patient’s bloodstream. 

The FDA said these emboli might obstruct blood flow and require additional interventions to remove device fragments. Obstructed blood flow can result in serious patient injuries such as stroke, kidney damage, damage to the intestines or limbs, or can cause patient death.

On Dec. 15, Boston Scientific sent an urgent medical device recall removal letter to their customers. In the letter they instructed customers to immediately stop using and quarantine any affected products. These products should be returned to the vendor.

Additionally, physicians are encouraged to contact all patients who have undergone procedures involving Chariot to confirm their post-procedure status, as device shaft separation and embolized fragments may not have been recognized at the time of the procedure.

The U.S. recall includes 5,692 units nationwide. The affected device manufacturing dates and between March 17, 2015 to Nov. 10, 2015 and had distribution dates from June 6, 2015 to Nov. 17, 2015

The Chariot Guiding Sheath is used to guide the placement of interventional and diagnostic devices into the veins and arteries of a patient’s arms, hands, legs or feet (peripheral vasculature).

The recall affects all UPNs of the Chariot Guiding Sheaths:

  • H74939277645110
  • H74939277745110
  • H74939277845110
  • H74939277645220
  • H74939277765120
  • H74939277690210
  • H74939277665110
  • H74939277790110
  • H74939277645120
  • H74939277865120
  • H74939277690220
  • H74939277690110
  • H74939277865110
  • H74939277745120
  • H74939277890120
  • H74939277845210
  • H74939277765110
  • H74939277545210
  • H74939277790210
  • H74939277845120
  • H74939277745210
  • H74939277545110
  • H74939277790220
  • H74939277790120
  • H74939277745220
  • H74939277645210
  • H74939277690120
  • H74939277665120
  • H74939277890110

Physicians and health care facilities with questions can contact their Boston Scientific representative or call (800) 811-3211.

 


Related Content

Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
News | Cath Lab

Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...

Home September 23, 2025
Home
Subscribe Now